Warning letter
Natural Path / Silver Wings, LLC [ARCHIVED]: warning letter of Apr 25, 2011
FDA warning letter 144172 · New Orleans District Office
Key facts
| Reference number | 144172 |
|---|---|
| Company | Natural Path / Silver Wings, LLC [ARCHIVED] |
| Subject | CGMP/Unapproved New Drug/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Apr 25, 2011 |
| Posted date | Apr 25, 2011 |
| Issuing office | New Orleans District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.93(g)(2)(iv), 111.83(a), 111.205(a), 111.80(a), 201.5, 310.548, 201.100(c)(2), 310.548(b) |
| Inspection city | White Bluff |
| Inspection ZIP | 37187 |
| Inspection start date | Aug 3, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: